Skip navigation
Login / Sign up
Your cart is empty
Please add a product
Show my Cart
Contact Us
English
Keywords
Search
Skip navigation
Beyond Exome
Test Catalog
How to order
Genetic Testing
Patients & Clinicians
About MGZ
Skip navigation
Polygenic Risk Score - Coronary artery diseases
Polygenic Risk Score - Breast Cancer
NIPT Monogenic
Liquid Biopsy
Optical Genome Mapping (OGM)
RNA-Sequencing
Repeat-Panel-Anaylses
FSHD testing
Epigenetic Signature
How to Order a Genetic Test
Cost & Billing Information
Sample Requirements
Shipping Instructions
Gene Panel Sequencing
Single Gene Analysis
Exome Sequencing
Repeat-Expansion Analysis
Methylation Analysis
Deletion/Duplication Analysis
Prenatal NGS analyses
Cytogenetics And Microarray Analysis
About Genetic Counseling
About Genetic Testing
Downloads
FAQ
What We Do
Why MGZ?
The MGZ Team
Quality Management
Menu
Skip navigation
Beyond Exome
Polygenic Risk Score - Coronary artery diseases
Polygenic Risk Score - Breast Cancer
NIPT Monogenic
Liquid Biopsy
Optical Genome Mapping (OGM)
RNA-Sequencing
Repeat-Panel-Anaylses
FSHD testing
Epigenetic Signature
Test Catalog
How to order
How to Order a Genetic Test
Cost & Billing Information
Sample Requirements
Shipping Instructions
Genetic Testing
Gene Panel Sequencing
Single Gene Analysis
Exome Sequencing
Repeat-Expansion Analysis
Methylation Analysis
Deletion/Duplication Analysis
Prenatal NGS analyses
Cytogenetics And Microarray Analysis
Patients & Clinicians
About Genetic Counseling
About Genetic Testing
Downloads
FAQ
About MGZ
What We Do
Why MGZ?
The MGZ Team
Quality Management
Test Catalog
Search
Back to Clinical Area
Gynecological Tumors - Breast and Ovarian Cancer
Breast and Ovarian Cancer
includes 14 Gene(s)
Breast Cancer
includes 38 Gene(s)
Ovarian Cancer
includes 15 Gene(s)
Ovarian Cancer - comprehensive Panel
includes 30 Gene(s)
PI3K inhibitors
includes 1 Gene(s)
Personalized therapy management, breast cancer
includes 8 Gene(s)
ESR1- and PIK3CA-variants for ER+/HER2- breast cancer
includes 2 Gene(s)
Personalized therapy management, breast cancer (Hotspot-regions in 6 Genes)
includes 6 Gene(s)
ESR1 Multiplex-hotspot-regions
includes 1 Gene(s)
Guardant360CDx, pan-cancer liquid biopsy
includes 74 Gene(s)
PARP inhibitor indication
includes 2 Gene(s)
Pan-Tumor Profiling, personalized therapy management
includes 27 Gene(s)